Imatinib Recruiting Phase 2 Trials for Plexiform Neurofibroma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03688568Study of Imatinib in Children With Neurofibromatosis and Airway Tumors